In a groundbreaking decision, the United States District Court for the Northern District of Texas has ordered the Food and Drug Administration (FDA) to release a trove of documents related to Pfizer’s COVID-19 vaccine trials. These documents, which the FDA initially sought to keep under wraps for 75 years, must now be made public by mid-2025. This ruling follows a heated legal battle spearheaded by the Public Health and Medical Professionals for Transparency (PHMPT).
The case originated from a Freedom of Information Act (FOIA) request filed by PHMPT. The organization, composed of scientists and public health professionals, demanded full access to the data used to grant Emergency Use Authorization (EUA) for Pfizer’s vaccine. In response, the FDA proposed a staggered release of 500 pages per month—a pace that would have delayed full disclosure until 2097.
Skip The Home Renovation Store! Get A Fresh New Look Here
The FDA justified its request by pointing to resource constraints and the sheer volume of over 300,000 pages of documents. However, critics viewed this timeline as a blatant attempt to shield the agency and Pfizer from scrutiny.
>> Click Here To Continue Reading <<
